EDIT NEWS why is Editas Medicine, Inc. price falling or rising

EDIT NEWS reasons for why stock price of Editas Medicine, Inc. is falling or rising

EDIT Editas Medicine is falling or rising technical reasons

Technical analysis forecast for Editas Medicine Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Editas Medicine EDIT at this time. Stock is falling and might fall more.

It appears as if Editas Medicine EDIT gave a large move recently.

Stock of Editas Medicine (EDIT) is trading below an important moving average line, and it has been below this line for quite some time now. This is not a good sign, stock might keep falling and stock might move lower...

My analysis of Editas Medicine is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if Editas Medicine stays below 5.5, but if it comes above 5.5, then a intra day buy could be more profitable.
If you take a sell trade below 5.5, then use 5.5 as stoploss and 4.7 as target. However if you take a buy trade in Editas Medicine, then use 5.5 as stoploss and 6.12 as target.

EDIT Editas Medicine is falling or rising NEWS fundamental reasons

Explained: 17,000 ICICI Bank credit cards blocked after data breach An old user was apparently able to get a look into a newly-acquired credit card customer's details because of the wrongful mapping, but the reverse was not possible. - NEWS as on 2024-04-26 business-standard.com

Jubilant Foodworks receives credit ratings from India Ratings and Research Term Loan (Rs 200 crore) - IND AA+/Stable (Affirmed) Proposed workinq Capital limit (Rs 100 crore) - IND AA+/Stable/ IND A 1 + (Affirmed) Term Loan (Rs 110 crore) - IND AA+/Stable (Assiqned) Proposed working capital limit (Rs 140 crore) - IND AA+/Stab - NEWS as on 2024-04-26 business-standard.com

Fund review: Kotak Credit Risk Fund Fund review: Kotak Credit Risk Fund - NEWS as on 2024-04-25 business-standard.com

17,000 credit cards mapped to wrong users, no misuse reported: ICICI Bank The second largest private sector lender, however, said that no instances of any misuse have been reported because of the error, and also promised to compensate users for any financial loss - NEWS as on 2024-04-25 business-standard.com

India Inc to tap private credit to finance new projects, says PwC Tax uncertainty is a big concern for PEs - NEWS as on 2024-04-24 business-standard.com

Rewards, lounge access downgrades: All changes to Axis Bank credit cards Axis Bank credit card changes will affect lounge access, rewards programmes, and additional services for various card tiers - NEWS as on 2024-04-23 business-standard.com

AU SFB launches multiple products like credit cards with exclusive features In a bid to increase fee income, AU Small Finance Bank (AU SFB) on Tuesday launched an array of products including Rupay credit card and ATM insurance. Among the latest offerings are two innovative credit cards: the AU SPONT Rupay Credit Card and Secured C - NEWS as on 2024-04-23 business-standard.com

Paytm unveils Made-in-India soundboxes for UPI, credit card on UPI payments Paytm on Monday launched two Made-in-India soundboxes for UPI and credit card on UPI payments. Paytm founder and CEO Vijay Shekhar Sharma said that the advanced soundboxes offer better sound quality and battery life, making them better suited to Indian con - NEWS as on 2024-04-22 business-standard.com

More announcements and NEWS

EDIT Editas Medicine, Inc. current price & indicator signals

Moving Averages for Editas Medicine, Inc.

  • 5Day Average: 5.39
  • 12Day Average: 5.69
  • 20Day Average: 6.16
  • 50Day Average: 7.61
  • 100Day Average: 8.26
  • 150Day Average: 8.25
  • 200Day Average: 8.34

EDIT Indicators & signals

Indicator MACD (12,26,9)

5.73, 6.38, -0.63
Indicator MACD is in negative zone

Indicator ADX (14)

30, 19.44, 36.11
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 65
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of EDIT Editas Medicine, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
26 Fri Apr 2024 5.32 5.13 to 5.40 1.92% 0.76 times
25 Thu Apr 2024 5.22 5.11 to 5.27 -2.43% 0.86 times
24 Wed Apr 2024 5.35 5.28 to 5.59 -2.01% 1.07 times
23 Tue Apr 2024 5.46 5.46 to 5.92 -2.5% 0.92 times
22 Mon Apr 2024 5.60 5.38 to 5.79 2% 0.98 times
19 Fri Apr 2024 5.49 5.29 to 5.68 -1.08% 1.27 times
18 Thu Apr 2024 5.55 5.51 to 5.68 -1.07% 0.96 times
17 Wed Apr 2024 5.61 5.60 to 5.93 -4.1% 1.07 times
16 Tue Apr 2024 5.85 5.85 to 6.03 -3.78% 0.75 times
15 Mon Apr 2024 6.08 5.98 to 6.29 -2.09% 0.99 times
12 Fri Apr 2024 6.21 6.13 to 6.53 -5.62% 1.13 times
11 Thu Apr 2024 6.58 6.44 to 6.77 -0.75% 0.83 times

Videos related to: EDIT NEWS why is Editas Medicine, Inc. price falling or rising

 Videos related to: EDIT NEWS why is Editas Medicine, Inc. price falling or rising

Hindi Basics How To Trade In FnO Futures Options Stock Market

EDIT NEWS why is Editas Medicine, Inc. price falling or rising

 

Back to top